Aetiology of mitral regurgitation differentially affects 2-year adverse outcomes after MitraClip therapy in high-risk patients.
Rudolph V, Lubos E, Schlüter M, Lubs D, Goldmann B, Knap M, de Vries T, Treede H, Schirmer J, Conradi L, Wegscheider K, Reichenspurner H, Blankenberg S, Baldus S.
Rudolph V, et al. Among authors: conradi l.
Eur J Heart Fail. 2013 Jul;15(7):796-807. doi: 10.1093/eurjhf/hft021. Epub 2013 Feb 20.
Eur J Heart Fail. 2013.
PMID: 23426023
Free article.